| 摘要 |
Preparation of 1-[ (3-(1-adamantyloxy)phenethyl]imidazoles and congeners- for example, 1-[ beta -(1-adamantyloxy)-4-chlorophenethyl]imidazole oxalate- and 3-(1-adamantyl)-1-[ ( beta -hydroxyl)halophenethyl] imidazolium bromide by-products, together with biological properties thereof including antibacterial, antiprotozoal, anthelmintic, antifungal, and antialgal activities, are disclosed.
|
